This was caused by impairment of the leptin-signal transduction mediated by both janus-activated kinase-2 and the mitogen-activated protein kinase pathway, leading finally to hypertriglyceridemia and hepatic steatosis [53]. This evidence concerns the gene LEP and fatty liver disease.